Literature DB >> 8225662

Endomyocardial biopsy in right ventricular cardiomyopathy.

A Angelini1, G Thiene, G M Boffa, I Calliari, L Daliento, M Valente, R Chioin, A Nava, S D Volta, I ] Calliaris I [corrected to Calliari.   

Abstract

Right ventricular cardiomyopathy is characterized by a progressive myocyte loss and fibro-fatty substitution of the right ventricle. The aim of our study was to assess the diagnostic accuracy of right ventricular endomyocardial biopsy. Using an imaging analyser system, histomorphometric parameters of myocytes, interstitium, fibrous tissue and fatty tissue were evaluated on endomyocardial biopsy from 30 patients with arrhythmogenic right ventricular cardiomyopathy, 29 patients with dilated cardiomyopathy and 30 control patients. The percent area of myocytes decreased from 78.10 +/- 7.34 in control to 63.39 +/- 9.22 in dilated cardiomyopathy (P < 0.05) and to 47.28 +/- 15.01 in arrhythmogenic right ventricular cardiomyopathy (P < 0.01). Fibrous tissue increased from 8.10 +/- 3.89 in control to 21.80 +/- 9.29 in dilated cardiomyopathy (P < 0.05) and to 24.60 +/- 11.37 in arrhythmogenic right ventricular cardiomyopathy (P < 0.05). Fatty tissue varied from 0.33 +/- 1.44 in control and 0.07 +/- 0.31 in dilated cardiomyopathy to 13.30 +/- 17.30 in arrhythmogenic right ventricular cardiomyopathy (P < 0.05). Fatty tissue was a feature of arrhythmogenic right ventricular cardiomyopathy (67% of patients vs. 6% of control and dilated cardiomyopathy patients). Diagnostic values typifying arrhythmogenic right ventricular cardiomyopathy, obtained by excluding any overlapping between confidence intervals in the three groups, were: myocytes < 44.95%; fibrous tissue > 40.38%, and fatty tissue > 3.21%, with 67% sensitivity and 91.53% specificity for at least one parameter. In conclusion, a significant difference between arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy and control exists in terms of amount of myocytes, fibrous tissue and fatty tissue. Presence of fatty tissue and fibrous tissue exceeding 3.21% and 40.38%, respectively should be considered highly suspect for arrhythmogenic right ventricular cardiomyopathy in right ventricular endomyocardial biopsy.

Entities:  

Mesh:

Year:  1993        PMID: 8225662     DOI: 10.1016/0167-5273(93)90011-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Complications of 2-D echocardiography guided transfemoral right ventricular endomyocardial biopsy.

Authors:  Juyup Han; Yongwhi Park; Hyunsang Lee; Hyunjae Kang; Hyungseop Kim; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

2.  Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy.

Authors:  L Menghetti; C Basso; A Nava; A Angelini; G Thiene
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

3.  In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy.

Authors:  M Valente; F Calabrese; G Thiene; A Angelini; C Basso; A Nava; L Rossi
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective.

Authors:  Kai Chen; Jiangping Song; Zhen Wang; Man Rao; Liang Chen; Shengshou Hu
Journal:  Clin Cardiol       Date:  2018-05-11       Impact factor: 2.882

5.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

Authors:  Jonathan G Howlett; Robert S McKelvie; J Malcolm O Arnold; Jeannine Costigan; Paul Dorian; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Philip Jong; Simon Kouz; Peter Liu; Elizabeth Mann; Gordon W Moe; Ross T Tsuyuki; Heather J Ross; Michel White
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

6.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

7.  Electrocardiographic and morphometric features in patients with ventricular tachycardia of right ventricular origin.

Authors:  J Kazmierczak; J De Sutter; R Tavernier; C Cuvelier; C Dimmer; L Jordaens
Journal:  Heart       Date:  1998-04       Impact factor: 5.994

8.  A case of arrhythmogenic right ventricular cardiomyopathy without arrhythmias.

Authors:  Jia Wei; Jiarong Tang; Liming Xia; Xinshan Chen; Dao Wen Wang
Journal:  Diagn Pathol       Date:  2012-06-12       Impact factor: 2.644

Review 9.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Gaetano Thiene; Domenico Corrado; Cristina Basso
Journal:  Orphanet J Rare Dis       Date:  2007-11-14       Impact factor: 4.123

10.  Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy.

Authors:  Xuebiao Li; Yu Nie; Hong Lian; Shengshou Hu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.